Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: A fox chase cancer center retrospective

Clinical Lung Cancer

Volumn 9, Issue 2, 2008, Pages 116-121

  Paralkar, Vikram R ^a   Li, Tianyu ^b   Langer, Corey J ^b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Bevacizumab; Carboplatin; Cranial irradiation; Nonmediastinal lymph nodes

Indexed keywords

ALBUMIN; BEVACIZUMAB; CARBOPLATIN; PLATINUM; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTIVARIATE ANALYSIS; PATIENT MONITORING; PATIENT SELECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SKULL IRRADIATION; UNIVARIATE ANALYSIS;

EID: 43049092669     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2008.n.018     Document Type: Article

References (17)

1. JH Schiller D Harrington CP Belani Comparison of four chemotherapy regimens for advanced non–small-cell lung cancer N Engl J Med 346 2002 92 98
2. A Sandler R Gray MC Perry Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [published correction appears in N Engl J Med 2007; 356:318] N Engl J Med 355 2006 2542 2550
3. KS Albain JJ Crowley M LeBlanc Survival determinants in extensive-stage non–small-cell lung cancer: the Southwest Oncology Group experience J Clin Oncol 9 1991 1618 1626
4. HA Wakelee P Bernardo DH Johnson Changes in the natural history of nonsmall cell lung cancer (NSCLC)—comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990 Cancer 106 2006 2208 2217
5. GA Silvestri LT Tanoue ML Margolis The noninvasive staging of non-small cell lung cancer: the guidelines Chest 123 1 suppl 2003 147S 156S
6. MD Brundage D Davies WJ Mackillop Prognostic factors in non-small cell lung cancer: a decade of progress Chest 122 2002 1037 1057
7. T Hoang R Xu JH Schiller Clinical model to predict survival in chemonaive patients with advanced non–small-cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group data J Clin Oncol 23 2005 175 183
8. SJ Mandrekar SE Schild SL Hillman A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials Cancer 107 2006 781 792
9. EL Kaplan P Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
10. JD Patel PB Bach MG Kris Lung cancer in US women: a contemporary epidemic JAMA 291 2004 1763 1768
11. Ries LA, Melbert D, Krapcho M, et al. (eds.) SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Available at: http://seer.cancer.gov/statfacts/html/lungb.html . Accessed: April 1, 2008.
12. PY Wen P McLaren Black JS Laeffler Metastatic brain cancer VT De Vita Jr S Hellman SA Rosenberg Cancer: Principles and Practice of Oncology 6th ed. 1999 Lippincott Williams and Wilkins Philadelphia, PA 2655 2670
13. G Frezza F Salvi Prophylactic cranial irradiation in non-small cell lung cancer Ann Oncol 17 suppl 2 2006 ii76 ii78
14. E Gore RTOG 0214: a phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer Clin Adv Hematol Oncol 3 2005 625 626
15. P Bonnette P Puyo C Gabriel Surgical management of non-small cell lung cancer with synchronous brain metastases Chest 119 2001 1469 1475
16. O Mercier E Fadel M de Perrot Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer J Thorac Cardiovasc Surg 130 2005 136 140
17. M Jiroutek D Johnson R Blum Prognostic factors in advanced NSCLC: analysis of ECOG trials from 1981–1992 Proc Am Soc Clin Oncol 17 1998 (Abstract 1774).